Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis-Reference-Cited by-同舟云学术

Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis

Published:2018-06 Issue:6 Volume:45 Page:738-752.e6
ISSN:1534-5807
Container-title:Developmental Cell
language:en
Short-container-title:Developmental Cell

Author:

Poudel Kumud R.,Roh-Johnson Minna,Su Allen,Ho Thuong,Mathsyaraja Haritha,Anderson Sarah,Grady William M.,Moens Cecilia B.,Conacci-Sorrell Maralice,Eisenman Robert N.,Bai Jihong

Funder

NIH

CPRIT

Welch

FHCRC/UW Cancer Consortium Cancer Center

Publisher

Elsevier BV

Subject

Developmental Biology,Cell Biology,General Biochemistry, Genetics and Molecular Biology,Molecular Biology

Reference94 articles.

1. Epigenetic and genetic features of 24 colon cancer cell lines;Ahmed;Oncogenesis,2013

2. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J. Clin. Oncol.,2008

3. MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation;Anderson;Proc. Natl. Acad. Sci. USA,2016

4. Direct interaction between metastasis-associated protein 1 and endophilin 3;Aramaki;FEBS Lett.,2005

5. A novel regulator of p21-activated kinases;Bagrodia;J. Biol. Chem.,1998

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophages directly kill bladder cancer cells through TNF signaling as an early response to BCG therapy;Disease Models & Mechanisms;2024-08-01

2. CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription;Cancer Cell International;2024-07-06

3. Deficiency in SPOP-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03

4. CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription;2024-02-12

5. Macrophages drive the earliest anti-tumoral response to BCG therapy by directly killing bladder cancer through TNF signaling;2024-01-05